Skin grafting on amputated lower limb, norepinephrine-induced ischemic limb necrosis – case report

1. Rao K., Tillo O., Dalal M. Full thickness skin graft cover for lower limb defects following excision of cutaneous lesions. Dermatol Online J. 2008, 14 (2): 4.

2. Oganesyan G., Jarell AD., Srivastava M., et al. Efficacy and complication rates of full‐thickness skin graft repair of lower extremity wounds after Mohs micrographic surgery. Dermatol Surg. 2013, 39 (9): 1334–1339.

3. Audrain H., Bray A., De Berker D. Full-thickness skin grafts for lower leg defects: an effective repair option. Dermatol Surg. 2015, 41 (4): 493–498.

4. Singer M., Deutschman CS., Seymour CW., et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016, 315 (8): 801–810.

5. Russell JA., Rush B., Boyd J. Pathophysiology of septic shock. Crit Care Clin. 2018, 34 (1): 43–61.

6. Gotts JE., Matthay MA. Sepsis: pathophysiology and clinical management. BMJ. 2016, 353: i1585.

7. Iba T., Levy JH. Inflammation and thrombosis: roles of neutrophils, platelets and endothelial cells and their interactions in thrombus formation during sepsis. J Thromb Haemost. 2018, 16 (2): 231–241.

8. Dellinger RP., Levy MM., Rhodes A., et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013, 39 (2): 165–228.

9. Asfar P., Meziani F., Hamel JF., et al. High versus low blood-pressure target in patients with septic shock. N Engl J Med. 2014, 370 (17): 1583–1593.

10. Lin C., Chen T., Lu P., et al. Lower initial central venous pressure in septic patients from long-term care facilities than in those from the community. J Microbiol Immunol Infect. 2014, 47 (5): 422–428.

11. Rhodes A., Evans L., Alhzzani W., et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock. Intensive Care Med. 2017, 43 (3): 304–377.

12. Scheeren TW., Bakker J., De Backer D., et al. Current use of vasopressors in septic shock. Ann Intensive Care. 2019, 9 (1): 20.

13. Auchet T., Regnier MA., Girerd N., et al. Out-come of patients with septic shock and high-dose vasopressor therapy. Ann Intensive Care. 2017, 7 (1): 43.

14. Landry DW., Levin HR., Gallant EM., et al. Vasopressin pressor hypersensitivity in vasodilatory septic shock. Crit Care Med. 1997, 25 (8): 1279–1282.

15. Malay MB., Ashton Jr RC., Landry DW., et al. Low-dose vasopressin in the treatment of vasodilatory septic shock. J Trauma. 1999, 47 (4): 699–703.

16. Bassi E., Park M., Azevedo LCP. Therapeutic strategies for high-dose vasopressor-dependent shock. Crit Care Res Pract. 2013, 2013: 654708.

17. Brown SM., Lanspa MJ., Jones JP., et al. Survival after shock requiring high-dose vasopressor therapy. Chest. 2013, 143 (3): 664–671.

18. Martin C., Medam S., Antonini F., et al. Norepinephrine: not too much, too long. Shock. 2015, 44 (4): 305–309.

19. Auchet T., Regnier MA., Girerd N., et al. Out-come of patients with septic shock and high-dose vasopressor therapy. Ann Intensive Care. 2017, 7 (1): 43.

20. Hamzaoui O., Scheeren TW., Teboul JL. Norepinephrine in septic shock: when and how much? Curr Opin Crit Care. 2017, 23 (4): 342–347.

21. Warkentin TE. Microvascular thrombosis and ischaemic limb losses in critically ill patients. Hämostaseologie. 2019, 39 (1): 6–19.

22. Levy JH., Ghadimi K., Faraoni D., et al. Ischemic limb necrosis in septic shock: what is the role of high‐dose vasopressor therapy? J Thromb Haemost. 2019, 17 (11): 1973–1978.

23. Reyes WJ., Brimioulle S., Vincent JL. Septic shock without documented infection: an uncommon entity with a high mortality. Intensive Care Med. 1999, 25 (11): 1267–1270.

24. Shi R., Hamzaoui O., De Vita N., et al. Vasopressors in septic shock: which, when, and how much? Ann Transl Med. 2020, 8 (12): 794.

25. O’Callaghan DJ., Gordon AC. What’s new in vasopressin? Intensive Care Med. 2015, 41 (12): 2177–2179.

26. Warkentin TE., Pai M. Shock, acute disseminated intravascular coagulation, and microvascular thrombosis: is “shock liver” the unrecognized provocateur of ischemic limb necrosis? J Thromb Haemost. 2016, 14 (2): 231–235.

27. Warkentin TE. Ischemic limb gangrene with pulses. N Engl J Med. 2015, 373 (7): 642–655.

28. Wada H., Takahashi H., Uchiyama T., et al. The approval of revised diagnostic criteria for DIC from the Japanese Society on Thrombosis and Hemostasis. Thromb J. 2017, 15: 17.

Kleanthia Efthymiou, MD
Trieda SNP 1
040 11 Košice
Slovakia
e-mail: kleanthiaefthimiou@hotmail.com

Submitted: 1. 6. 2023
Accepted: 4. 1. 2024